Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,849 | -30,125 | -13,694 | -33,947 | -21,801 |
| Depreciation Amortization | 191 | 85 | 43 | 144 | 106 |
| Accounts payable and accrued liabilities | 362 | 1,685 | 1,533 | 664 | 673 |
| Other Working Capital | 1,279 | 855 | 236 | -360 | -374 |
| Other Operating Activity | 9,337 | 5,049 | 1,313 | 3,209 | 1,184 |
| Operating Cash Flow | $-38,680 | $-22,451 | $-10,569 | $-30,290 | $-20,212 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,735 | -449 | -125 | -57 | -25 |
| Other Investing Activity | -400 | -400 | -400 | 0 | 0 |
| Investing Cash Flow | $-3,135 | $-849 | $-525 | $-57 | $-25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 112,972 | -367 | 13 | 113,496 | 340 |
| Other Financing Activity | 0 | 0 | 0 | 72,434 | 72,434 |
| Financing Cash Flow | $112,972 | $-367 | $13 | $185,930 | $72,774 |
| Beginning Cash Position | 155,974 | 155,974 | 155,974 | 391 | 391 |
| End Cash Position | 227,131 | 132,307 | 144,893 | 155,974 | 52,928 |
| Net Cash Flow | $71,157 | $-23,667 | $-11,081 | $155,583 | $52,537 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,680 | -22,451 | -10,569 | -30,290 | -20,212 |
| Capital Expenditure | -2,735 | -449 | -125 | -57 | -25 |
| Free Cash Flow | -41,415 | -22,900 | -10,694 | -30,347 | -20,237 |